A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 31 550 KRW -4.54%
Market Cap: 1.5T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Capital Expenditures Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Capital Expenditures
-â‚©9.3B
CAGR 3-Years
-82%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Capital Expenditures
-â‚©350.4B
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
SK Bioscience Co Ltd
KRX:302440
Capital Expenditures
-â‚©50.3B
CAGR 3-Years
-70%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Capital Expenditures
-â‚©34.1B
CAGR 3-Years
8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Capital Expenditures
-â‚©27.5B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Capital Expenditures
-â‚©33.4B
CAGR 3-Years
-35%
CAGR 5-Years
-28%
CAGR 10-Years
N/A

See Also

What is ABL Bio Inc's Capital Expenditures?
Capital Expenditures
-9.3B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Capital Expenditures amounts to -9.3B KRW.

What is ABL Bio Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-54%

Over the last year, the Capital Expenditures growth was -564%. The average annual Capital Expenditures growth rates for ABL Bio Inc have been -82% over the past three years , -54% over the past five years .

Back to Top